Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Yumanity Therapeutics revenue
Yumanity Therapeutics's revenue is $1.9 billion.
What is Yumanity Therapeutics's revenue?
- Yumanity Therapeutics's revenue growth from 2015 to 2016 is 5.21%.
- Yumanity Therapeutics has 23,876 employees, and the revenue per employee ratio is $78,183.
- Yumanity Therapeutics peak revenue was $1.9B in 2016.
- Yumanity Therapeutics annual revenue for 2016 was 1.9B, 5.21% growth from 2015.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Yumanity Therapeutics financial information
| CEO | Meenu Chhabra |
| Company Type | Public |
| Employees Number | 23,876 |
| Date Founded | 2014 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 2 |
| Revenue | $1.9B |
| Net Income | $31,700,000 |
| Gross Proft | $545.6M (2016) |
| Tax Rate | -2.2% |
| Total Assets | $2,589,600,000 |
| Ticker | PTI |
Yumanity Therapeutics jobs you might like
Yumanity Therapeutics financing
Yumanity Therapeutics received early financing of $45.0M on 2008-08-25.
| Series | Round size | Date |
|---|---|---|
| Series A | $45M | 08/2008 |
| Series Unknown | $20M | 03/2011 |
| Debt Financing | $3M | 08/2014 |
| Series B | $37M | 09/2015 |
Yumanity Therapeutics investors
| Investors | Security type |
|---|---|
| Novartis Venture Fund | Series A |
| New Enterprise Associates (NEA) | Series A |
| Healthcare Ventures LLC | Series A |
| Sanofi Ventures | Series A |
| F Prime Capital | Series A |
| Elan Corporation | Series Unknown |
| Novartis Venture Fund | Series B |
| New Enterprise Associates (NEA) | Series B |
| Healthcare Ventures LLC | Series B |
| Cormorant Asset Management | Series B |
| Sanofi Ventures | Series B |
| F Prime Capital | Series B |
| Rock Springs Capital | Series B |
Search for jobs
Yumanity Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Yumanity Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Yumanity Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Yumanity Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Yumanity Therapeutics. The data presented on this page does not represent the view of Yumanity Therapeutics and its employees or that of Zippia.
Yumanity Therapeutics may also be known as or be related to PROTEOSTASIS THERAPEUTICS, INC., Proteostasis Therapeutics, Proteostasis Therapeutics Inc, Proteostasis Therapeutics, Inc. and Yumanity Therapeutics.